Phio Pharmaceuticals Financials

PHIO Stock  USD 2.64  0.00  0.00%   
Based on the key indicators related to Phio Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Phio Pharmaceuticals Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At this time, Phio Pharmaceuticals' Cash And Short Term Investments are very stable compared to the past year. As of the 28th of November 2024, Common Stock Shares Outstanding is likely to grow to about 243.1 K, while Short and Long Term Debt Total is likely to drop about 33.2 K. Key indicators impacting Phio Pharmaceuticals' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio4.295.705
Way Down
Slightly volatile
The essential information of the day-to-day investment outlook for Phio Pharmaceuticals includes many different criteria found on its balance sheet. An individual investor should monitor Phio Pharmaceuticals' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Phio Pharmaceuticals.

Net Income

(11.37 Million)

  
Understanding current and past Phio Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Phio Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Phio Pharmaceuticals' assets may result in an increase in income on the income statement.

Phio Pharmaceuticals Stock Summary

Phio Pharmaceuticals competes with Bright Minds, HP, Intel, Chevron Corp, and Coca Cola. Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. Phio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS71880W3034
CUSIP74979C303 74979C501 71880W303 74979C808 71880W402 71880W204 71880W501 74979C105
LocationMassachusetts; U.S.A
Business Address11 Apex Drive,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitephiopharma.com
Phone(508) 767 3861
CurrencyUSD - US Dollar

Phio Pharmaceuticals Key Financial Ratios

Phio Pharmaceuticals Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets8.0M15.7M25.2M12.8M9.4M12.4M
Other Current Liab27K1.2M2.5M890K907K1.2M
Net Debt(6.4M)(13.6M)(23.8M)(11.5M)(8.5M)(8.9M)
Retained Earnings(94.8M)(103.6M)(116.9M)(128.4M)(139.2M)(132.2M)
Accounts Payable809K728K283K779K657K647.1K
Cash6.9M14.2M24.1M11.8M8.5M10.8M
Other Current Assets316K920K670K665K832K489.5K
Total Liab2.3M2.7M3.2M2.0M1.6M3.1M
Total Current Assets7.3M15.2M24.7M12.4M9.3M12.1M
Net Tangible Assets13.6M5.7M13.0M21.9M25.2M26.5M
Capital Surpluse80.4M99.5M100.6M116.6M134.1M86.0M
Net Invested Capital5.7M13.2M21.9M10.8M7.7M11.8M
Net Working Capital5.4M13.0M21.7M10.5M7.7M11.5M

Phio Pharmaceuticals Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash(7.9M)7.3M9.8M(12.3M)(3.3M)(3.2M)
Free Cash Flow(8.7M)(8.8M)(11.9M)(12.3M)(10.8M)(11.3M)
Depreciation67K72K75K193K184K115.8K
Other Non Cash Items109K111K117K304K126K119.7K
Capital Expenditures5K72K19K51K121K4.8K
Net Income(8.9M)(8.8M)(13.3M)(11.5M)(10.8M)(11.4M)
End Period Cash Flow7.0M14.3M24.1M11.8M8.5M10.8M
Investments(5K)(72K)(19K)(51K)(121K)(5.3K)
Change To Netincome282K409K247K364K327.6K542.3K

Phio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Phio Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Phio Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phio Pharmaceuticals competition to find correlations between indicators driving Phio Pharmaceuticals's intrinsic value. More Info.
Phio Pharmaceuticals Corp is considered to be number one stock in return on equity category among its peers. It is regarded third in return on asset category among its peers . At this time, Phio Pharmaceuticals' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Phio Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Phio Pharmaceuticals Corp Systematic Risk

Phio Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Phio Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Phio Pharmaceuticals Corp correlated with the market. If Beta is less than 0 Phio Pharmaceuticals generally moves in the opposite direction as compared to the market. If Phio Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Phio Pharmaceuticals Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Phio Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Phio Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Phio Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Phio Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Phio Pharmaceuticals growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.002907

At this time, Phio Pharmaceuticals' Price Earnings To Growth Ratio is very stable compared to the past year.

Phio Pharmaceuticals November 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Phio Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Phio Pharmaceuticals Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Phio Pharmaceuticals Corp based on widely used predictive technical indicators. In general, we focus on analyzing Phio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Phio Pharmaceuticals's daily price indicators and compare them against related drivers.
When determining whether Phio Pharmaceuticals Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phio Pharmaceuticals Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phio Pharmaceuticals Corp Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(14.81)
Return On Assets
(0.61)
Return On Equity
(1.27)
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.